+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Latent TB Testing Market - Global Forecast 2025-2030- Product Image
Latent TB Testing Market - Global Forecast 2025-2030- Product Image
Sale

Latent TB Testing Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055453
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The latent tuberculosis (TB) testing market is advancing rapidly, driven by global demand for innovative diagnostics, evolving health strategies, and expanding regional initiatives. Decision-makers now operate in an environment shaped by advanced technologies and shifting regulatory frameworks, making optimized latent TB detection essential for public health success.

Market Snapshot: Latent TB Testing Market Growth

The Latent TB Testing Market grew from USD 1.29 billion in 2024 to USD 1.36 billion in 2025. It is projected to continue expanding at a CAGR of 5.70%, reaching USD 1.80 billion by 2030. These figures reflect strong ongoing investment in diagnostic tools and supply chain enhancements as healthcare systems worldwide prioritize the detection and control of latent TB infections.

Scope & Segmentation

  • Product Types: Instruments, kits, and reagents vital to diagnostic workflows.
  • Test Types: Interferon Gamma Release Assays (chemiluminescence, ELISA) and Tuberculin Skin Tests (intradermal, multipuncture).
  • Sample Types: Blood, plasma, and serum, each with unique processing and deployment benefits.
  • Applications: Diagnostic testing, research (new test and vaccine development); screening for health check-ups and immigration protocols.
  • End Users: Diagnostic centres, hospital laboratories, public health departments, and research institutes.
  • Distribution Channels: Direct sales and third-party distributors frame market reach and service models.
  • Geographies: Coverage includes Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, among others).
  • Company Coverage: Analysis features key industry participants such as Abbott Laboratories, Beckman Coulter, Becton, Dickinson and Company, bioMérieux SA, Cepheid, Danaher, DiaSorin, F. Hoffmann-La Roche AG, Fujifilm Holdings, Hologic, Oxford Immunotec, Siemens Healthineers, Thermo Fisher Scientific, and others.
  • Technologies: Market evolution centers on immunoassay platforms, digital connectivity for remote monitoring, and data-driven workflow optimization.

Key Takeaways for B2B Decision-Makers

  • Latent TB testing is at a pivotal juncture, integrating next-generation detection platforms and digital management tools to meet growing clinical needs.
  • Transition from traditional skin testing to immunologic assays delivers enhanced specificity but brings requirements for tighter assay standardization and interoperability among systems.
  • Decentralized and point-of-care diagnostics are expanding access, particularly in resource-limited markets, fueling wider adoption and partnered service models.
  • Regulatory evolution supports faster product introductions, as harmonized standards and streamlined processes encourage innovation and accelerate access to new testing solutions.
  • Stakeholders navigating fragmented supply chains are prioritizing localized manufacturing, collaborative purchasing, and cross-border alliances to ensure reliability and operational resilience.
  • Ongoing research in novel antigens, vaccine-related testing, and data analytics continues to shape product development and differentiate market leaders.

Tariff Impact: Navigating Trade Dynamics

The introduction of United States tariffs in 2025 has increased complexity for stakeholders across the latent TB testing value chain. Higher duties on key imported components and reagents have raised production costs, prompting manufacturers and distributors to pursue regional manufacturing strategies and renegotiate service and sourcing arrangements. Inventory planning, risk sharing, and cost-of-ownership models have emerged as leading responses, supporting resilience in procurement and sustained access for end users.

Methodology & Data Sources

This report integrates primary interviews with subject matter experts and comprehensive secondary research from peer-reviewed literature, regulatory filings, and market data. The combination of desk-based research and industry interviews ensures a holistic and accurate analysis of market dynamics, segmentation, and competitive positioning.

Why This Report Matters for Senior Decision-Makers

  • Gain actionable insights into critical growth drivers, evolving regulations, and innovative business models shaping the latent tuberculosis testing landscape.
  • Leverage detailed segmentation and regional strategies to optimize market entry, product development, and procurement planning.
  • Understand the implications of supply chain disruption, cost management, and cross-sector partnerships for long-term operational success.

Conclusion

The latent TB testing market is defined by ongoing innovation, regulatory adaptation, and emerging partnerships. Senior leaders equipped with strategic insights from this report will be well positioned to shape effective solutions and drive value in the evolving market.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising awareness and screening programs targeting latent TB among vulnerable populations
5.2. Integration of AI and machine learning in interpreting latent TB test results
5.3. Collaborations between public and private sectors to expand latent TB testing infrastructure
5.4. Development of novel biomarkers to improve sensitivity and specificity of tests
5.5. Concerns related to latent TB testing within high-burden and resource-limited regions
5.6. Increasing government funding and initiatives supporting latent TB identification
5.7. Emergence of point-of-care testing solutions enhancing latent TB screening access
5.8. Impact of COVID-19 on latent TB testing demand and healthcare priorities
5.9. Growing adoption of interferon-gamma release assays in latent TB testing globally
5.10. Advancements in rapid diagnostic techniques improving latent TB detection accuracy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Latent TB Testing Market, by Product Type
8.1. Introduction
8.2. Instruments
8.3. Kits
8.4. Reagents
9. Latent TB Testing Market, by Test Type
9.1. Introduction
9.2. Interferon Gamma Release Assays (IGRAs)
9.2.1. Chemiluminescence
9.2.2. ELISA (Enzyme-Linked Immunosorbent Assay)
9.3. Tuberculin Skin Test (TST)
9.3.1. Intradermal
9.3.2. Multipuncture
10. Latent TB Testing Market, by Sample Type
10.1. Introduction
10.2. Blood
10.3. Plasma
10.4. Serum
11. Latent TB Testing Market, by Application
11.1. Introduction
11.2. Diagnostic Testing
11.3. Research
11.3.1. New Test Development
11.3.2. Vaccine Development
11.4. Screening
11.4.1. Health Check-Ups
11.4.2. Immigration Screening
12. Latent TB Testing Market, by End User
12.1. Introduction
12.2. Diagnostic Centres
12.3. Hospital Laboratories
12.4. Public Health Departments
12.5. Research Institutes
13. Latent TB Testing Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Third-Party Distributor
14. Americas Latent TB Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Latent TB Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Latent TB Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Beckman Coulter, Inc.
17.3.3. Becton, Dickinson and Company (BD)
17.3.4. Bio-Rad Laboratories, Inc.
17.3.5. Biocare Medical, LLC
17.3.6. bioMérieux SA
17.3.7. Cepheid, Inc.
17.3.8. Danaher Corporation
17.3.9. DiaSorin S.p.A.
17.3.10. Eiken Chemical Co., Ltd.
17.3.11. ElitechGroup SAS by Bruker Company
17.3.12. F. Hoffmann-La Roche AG
17.3.13. Fujifilm Holdings Corporation
17.3.14. Hologic, Inc.
17.3.15. Mabtech AB
17.3.16. Meridian Bioscience, Inc.
17.3.17. Oxford Immunotec Limited by PerkinElmer, Inc.
17.3.18. Qiagen N.V.
17.3.19. Siemens Healthineers AG
17.3.20. Thermo Fisher Scientific Inc.
17.3.21. Tosoh Bioscience, Inc.
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. LATENT TB TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LATENT TB TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LATENT TB TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LATENT TB TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LATENT TB TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LATENT TB TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LATENT TB TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LATENT TB TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LATENT TB TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. LATENT TB TESTING MARKET: RESEARCHAI
FIGURE 28. LATENT TB TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. LATENT TB TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. LATENT TB TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LATENT TB TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LATENT TB TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LATENT TB TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LATENT TB TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LATENT TB TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LATENT TB TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LATENT TB TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LATENT TB TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LATENT TB TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LATENT TB TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LATENT TB TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LATENT TB TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LATENT TB TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LATENT TB TESTING MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY), BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LATENT TB TESTING MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY), BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LATENT TB TESTING MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LATENT TB TESTING MARKET SIZE, BY INTRADERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LATENT TB TESTING MARKET SIZE, BY MULTIPUNCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LATENT TB TESTING MARKET SIZE, BY MULTIPUNCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LATENT TB TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LATENT TB TESTING MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LATENT TB TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LATENT TB TESTING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LATENT TB TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LATENT TB TESTING MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LATENT TB TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LATENT TB TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LATENT TB TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LATENT TB TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LATENT TB TESTING MARKET SIZE, BY NEW TEST DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LATENT TB TESTING MARKET SIZE, BY NEW TEST DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LATENT TB TESTING MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LATENT TB TESTING MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LATENT TB TESTING MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LATENT TB TESTING MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LATENT TB TESTING MARKET SIZE, BY HEALTH CHECK-UPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LATENT TB TESTING MARKET SIZE, BY HEALTH CHECK-UPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LATENT TB TESTING MARKET SIZE, BY IMMIGRATION SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LATENT TB TESTING MARKET SIZE, BY IMMIGRATION SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LATENT TB TESTING MARKET SIZE, BY DIAGNOSTIC CENTRES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LATENT TB TESTING MARKET SIZE, BY DIAGNOSTIC CENTRES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LATENT TB TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LATENT TB TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LATENT TB TESTING MARKET SIZE, BY PUBLIC HEALTH DEPARTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LATENT TB TESTING MARKET SIZE, BY PUBLIC HEALTH DEPARTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LATENT TB TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LATENT TB TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LATENT TB TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LATENT TB TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LATENT TB TESTING MARKET SIZE, BY THIRD-PARTY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LATENT TB TESTING MARKET SIZE, BY THIRD-PARTY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 84. AMERICAS LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 85. AMERICAS LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 86. AMERICAS LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 87. AMERICAS LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LATENT TB TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LATENT TB TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 123. CANADA LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. CANADA LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. CANADA LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 128. CANADA LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 129. CANADA LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 130. CANADA LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 131. CANADA LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 136. CANADA LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 137. CANADA LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 138. CANADA LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 139. CANADA LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. CANADA LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. CANADA LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. CANADA LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. MEXICO LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 148. MEXICO LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 149. MEXICO LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 150. MEXICO LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 151. MEXICO LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 156. MEXICO LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 158. MEXICO LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 159. MEXICO LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. MEXICO LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. MEXICO LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 168. BRAZIL LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 169. BRAZIL LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 170. BRAZIL LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 171. BRAZIL LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA LATENT TB TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. GERMANY LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 248. GERMANY LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 250. GERMANY LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 251. GERMANY LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 252. GERMANY LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 253. GERMANY LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 258. GERMANY LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 259. GERMANY LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 260. GERMANY LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 261. GERMANY LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. GERMANY LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. GERMANY LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. GERMANY LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. FRANCE LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. FRANCE LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 270. FRANCE LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 271. FRANCE LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 272. FRANCE LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 273. FRANCE LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 274. FRANCE LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 275. FRANCE LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. FRANCE LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. FRANCE LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 278. FRANCE LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 279. FRANCE LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 280. FRANCE LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 281. FRANCE LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. FRANCE LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. FRANCE LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. FRANCE LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 290. RUSSIA LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 291. RUSSIA LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 292. RUSSIA LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 293. RUSSIA LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. ITALY LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. ITALY LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. ITALY LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 310. ITALY LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 311. ITALY LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 312. ITALY LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 313. ITALY LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 314. ITALY LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 315. ITALY LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. ITALY LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. ITALY LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 318. ITALY LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 319. ITALY LATENT TB TESTING MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 320. ITALY LATENT TB TESTING MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 321. ITALY LATENT TB TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. ITALY LATENT TB TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. ITALY LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. ITALY LATENT TB TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. SPAIN LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. SPAIN LATENT TB TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. SPAIN LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 328. SPAIN LATENT TB TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 329. SPAIN LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2018-2024 (USD MILLION)
TABLE 330. SPAIN LATENT TB TESTING MARKET SIZE, BY INTERFERON GAMMA RELEASE ASSAYS (IGRAS), 2025-2030 (USD MILLION)
TABLE 331. SPAIN LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2018-2024 (USD MILLION)
TABLE 332. SPAIN LATENT TB TESTING MARKET SIZE, BY TUBERCULIN SKIN TEST (TST), 2025-2030 (USD MILLION)
TABLE 333. SPAIN LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 334. SPAIN LATENT TB TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 335. SPAIN LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 336. SPAIN LATENT TB TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 337. SPAIN LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 338. SPAIN LATENT TB TESTING MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 339. SPAIN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Latent TB Testing market report include:
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Biocare Medical, LLC
  • bioMérieux SA
  • Cepheid, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eiken Chemical Co., Ltd.
  • ElitechGroup SAS by Bruker Company
  • F. Hoffmann-La Roche AG
  • Fujifilm Holdings Corporation
  • Hologic, Inc.
  • Mabtech AB
  • Meridian Bioscience, Inc.
  • Oxford Immunotec Limited by PerkinElmer, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Bioscience, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.36 billion
Forecasted Market Value ( USD ) by 2030 $ 1.8 billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Image

Latent TB Testing Market (2025 Edition): Analysis By Test Type (Tuberculin Skin Test (TST), and Interferon Gamma Released Assay (IGRA)), By End User, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • 198 Pages
  • Global
From
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living With HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029 - Product Image

Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living With HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029

  • Report
  • 261 Pages
  • Global
From
Tuberculosis Diagnostics Test Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Tuberculosis Diagnostics Test Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 145 Pages
  • Global
From
Latent TB Diagnostics Market 2025-2029 - Global Market Analysis and Forecasts by Assay, Risk Factor, and Lab/Place, with Executive and Consultant Guides - Product Image

Latent TB Diagnostics Market 2025-2029 - Global Market Analysis and Forecasts by Assay, Risk Factor, and Lab/Place, with Executive and Consultant Guides

  • Report
  • 322 Pages
  • Global
From
Tuberculosis Diagnostics Market Report 2025 - Product Image

Tuberculosis Diagnostics Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.